Avances y promesas: la investigación en 2023
Los resultados de la fase I del estudio, publicados en mayo en Nature, indican que la mitad de los 29 pacientes con cáncer de páncreas que ...
una investigación publicada
El estudio CAPS-5 y otros programas de vigilancia han demostrado que el cáncer de páncreas se puede detectar de forma precoz si sabemos qué pacientes podrían beneficiarse. Sin embargo, el problema es que la mayoría de los casos de cáncer de páncreas se presentan en personas sin factores de riesgo conocidos. Los estudios con inteligencia artificial (IA) son prometedores. Por ejemplo, <anchor>una investigación publicada</anchor> en Nature Medicine en mayo de 2023 sugiere que el uso de IA para hacer detección en grandes grupos, comenzando con la historia clínica, podría permitir el diagnóstico más temprano del cáncer de páncreas. Esto, a su vez, podría conducir a un tratamiento más temprano y eficaz de la enfermedad. En el análisis, una herramienta de IA identificó a personas con alto riesgo de cáncer de páncreas al revisar sus historias clínicas y encontrar indicios de un mayor riesgo hasta tres años antes de que fueran diagnosticadas.
AI Tool for Earlier Detection - Let's Win Pancreatic Cancer
Toggle navigation

August 22, 2023 • 5 Min

# New AI Tool Brings Hope in Quest for Earlier Detection

Dr. Michael Rosenthal

Whether it’s OpenAI’s ChatGPT or Google’s Bard AI, 2023 is the year that artificial intelligence has dominated the virtual water cooler.

In medicine, AI is already assisting in myriad ways. To name a few, AI can enhance diagnostics through analysis of big data and aid radiologists in interpreting images. It’s even helping to personalize medical treatment and in the diagnosis of disease.

## Pancreatic Cancer Screening Status

Screening for common cancers like breast, cervix, and prostate cancer relies on relatively simple and highly effective techniques, such as mammograms, Pap smears, and blood tests. These methods have revolutionized outcomes for those cancers by enabling early detection and intervention during the most treatable stages.

For pancreatic cancer, the picture is very different because there is no easy screening test. The disease is very often diagnosed in later stages, due to the location of the pancreas deep in the abdomen and the often-vague early symptoms. The late diagnosis contributes significantly to the low survival rate for pancreatic cancer.

People at high risk for developing pancreatic cancer—those with certain genetic mutations, a family history of the disease, or an identified pancreatic cyst—are urged to undergo regular screening. But pancreatic cancer screening is more challenging than a mammogram. It generally involves blood tests, endoscopic ultrasounds and MRIs given at specific intervals. Although research shows high-risk screening is beneficial to patients, it can be difficult to access if patients live far from academic medical centers, where most of the research takes place. It can also be costly.

Most pancreatic cancers occur randomly, and the disease is rare compared to such cancers as breast or prostate, so mass screening of asymptomatic patients for pancreatic cancer is not recommended at this time.

## Predicting Pancreatic Cancer Three Years Before Diagnosis

Research published in May 2023 in Nature Medicine suggests that AI screening of large groups of patients beginning with their medical records could make earlier diagnosis of pancreatic cancer possible. That, in turn, could lead to earlier and more effective treatment of the disease.

“It’s a remarkable study and we’re all very excited about it,” says study co-author Michael H. Rosenthal, M.D., Ph.D., Assistant Director of Radiology, Pancreas and Biliary Tumor Center of Dana-Farber Brigham Cancer Center (Boston, Massachusetts). “This is a great example of the cool and wonderful things that AI can do. Finding the subtle sense of cancer among diagnostic codes around the world really gave us the sense that we are on the right track.”

In the analysis, an AI tool successfully pinpointed people at elevated risk for pancreatic cancer by looking back at their medical records, finding evidence of heightened risk up to three years before they were diagnosed.

Researchers used data from the medical records of patients in both the United States and Denmark dating from 1977 to 2020. They looked at a group of 6.2 million Danish patients, 23,985 of whom were eventually diagnosed with pancreatic cancer, and 3 million American military veterans receiving care through the Department of Veterans Affairs, of whom 3,864 were ultimately diagnosed with the disease.

The researchers used a machine-learning model to analyze the data, teaching it to predict cancer risk based on symptoms and the various diagnosis codes contained in patients’ medical records. These various diagnostic codes included some symptoms not generally associated with pancreatic cancer. That, Rosenthal points out, is very important. “We added in common problems like gallstones, anemia, type 2 diabetes, vomiting, and stomach pain,” he says. “Those are common complaints and sometimes that’s all they are. But in the model, these symptoms helped in prediction of pancreatic cancer. And that prediction could be up to three years before actual diagnosis.”

The researchers say if this tool were in practice today, about 7 percent of the people the AI model identified as being in the 0.1 percent highest risk group would go on to develop pancreatic cancer within one year. By targeting surveillance to high-risk patients, the tool could make screening more affordable, they write.

## Teaching a Machine to Learn

Machine learning is a complicated type of AI. In simplest terms, the researchers trained or “asked” the AI tool to look for well-known and subtle signs based on the data contained in the health records. Based on the various combinations of disease codes for each patient, as well as their time sequence, the tool learned how to predict which patients were most likely to develop pancreatic cancer at some point in the future. “Every time you go to the doctor there is a wealth of information collected about you the patient,” Rosenthal notes. “Sometimes it is glaringly obvious as to what a patient should do and look out for if that patient has high blood pressure and a family history of heart disease. But it’s difficult to put all different types of seemingly disparate information together to see commonalities or what potentially might happen in the future.” For example, he says, “a lot of the symptoms we used and their related diagnostic codes were not directly related to pancreatic cancer. And some didn’t even originate from the pancreas.”

The researchers tested different versions of the AI models at six months, one year, two years, and three years. Each version of the AI tool was significantly more accurate at predicting who would develop pancreatic cancer than current population-wide estimates of disease incidence, the researchers say. The researchers also say the AI tool is at least as accurate in predicting pancreatic cancer occurrence as current genetic sequencing tests, which are limited to a small subset of patients. “These are still early days and we need to do more studies,” Rosenthal adds. “But if the data keeps moving in this direction it is possible that screening and earlier detection could happen in pancreatic cancer. That would be an incredible win for our patients.”

##### Tags

#### Follow Us

## Recent Stories

September 13, 2024 • 5 Min

### No Time for Self-Pity

September 10, 2024 • 3 Min

### A New Combination Targeting the RAS Pathway

September 5, 2024 • 3 Min

### AVENGER 500 Clinical Trial Shows No Overall Survival Benefit

## What are the risk factors for pancreatic cancer?



## More Screening and Early Detection

July 29, 2024 • 6 Min

### New Liquid Biopsy Shows Promise for Early Detection

Dr. Ajay Goel has a new approach to a liquid biopsy early detection test for pancreatic cancer. So far, the results are very impressive.

April 29, 2024 • 5 Min

### 2024 AACR Meeting Update

Some of the highlights of the latest pancreatic cancer research from the 2024 AACR meeting include the mRNA vaccine, and a liquid biopsy.

April 16, 2024 • 5 Min

### Felix 2.0 Builds Upon Artificial Intelligence Earlier Detection Successes

Can artificial intelligence help find pancreatic cancer sooner? Dr. Elliot Fishman thinks so, and has been working to make it happen.



422 E. 72nd Street #9F

New York, NY 10021212-359-9390

Let’s Win Pancreatic Cancer is an online community for sharing information about innovative, science-based treatments for pancreatic cancer. Please note that this information is not intended to be a substitute for professional medical opinion, advice, or diagnosis. We encourage you to use this information to begin a dialogue with your physician about the treatment plan that is right for you.

© 2024 | Let's Win Pancreatic Cancer is a 501(c)(3) nonprofit organization.

protected by reCAPTCHA

×

##### Save Articles with an account

After signing in, you can save articles and easily revisit them on any device.

Already have an account? Sign in